BR0011427A - Tricyclic painkillers - Google Patents

Tricyclic painkillers

Info

Publication number
BR0011427A
BR0011427A BR0011427-8A BR0011427A BR0011427A BR 0011427 A BR0011427 A BR 0011427A BR 0011427 A BR0011427 A BR 0011427A BR 0011427 A BR0011427 A BR 0011427A
Authority
BR
Brazil
Prior art keywords
alkyl
hydrogen
cycloalkyl
alkenyl
hydroxy
Prior art date
Application number
BR0011427-8A
Other languages
Portuguese (pt)
Inventor
Alain Calvet
Henri Jacobelli
Jocelyne Puaud
Francois J Roman
Jacques Hamon
Agnes Grouhel
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR0011427A publication Critical patent/BR0011427A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20Spiro-condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Patente de Invenção: "ANALGéSICOS TRICìCLICOS". Um composto tricíclico de Fórmula (I): em que: R^ 1^ é hidrogênio ou hidróxi; R^ 2^ é hidrogênio ou hidróxi; ou R^ 1^ e R^ 2^ juntos são oxigênio; A é uma ligação, CH~ 2~, CHCH~ 3~, CH~ 2~CH~ 2~ ou C(CH~ 3~)~ 2~; R^ 3^ e R^ 4^ são idênticos ou diferentes e são hidrogênio, halo, C~ 1-6~ alquila, C~ 1-4~ alcóxi, triflúor metila, NO~ 2~, COR^ 6^, COOR^ 6^ ou NR^ 6^R^ 7^, em que R^ 6^ e R^ 7^ são idênticos ou diferentes e são hidrogênio, C~ 1-6~ alquila ou benzila; R^ 5^ é hidrogênio, C~ 1-6~ alquila, C~ 2-6~ alquenila, C~ 3-6~ cicloalquila, (O=C)-C~ 1-6~ alquila, (O=C)-C~ 2-6~ alquenila, (O=C)-C~ 3-6~ cicloalquila, em que os ditos grupos alquila, alquenila e cicloalquila podem estar substituídos com 1, 2 ou 3 grupos selecionados de halo, C~ 3-6~ cicloalquila, fenila ou fenila substituída, e seus sais, são particularmente úteis para tratamento entre outras indicações, de dor neuropática e outros desordens CNS.Invention Patent: "TRICYCLICAL ANALGESICS". A tricyclic compound of Formula (I): wherein: R ^ 1 ^ is hydrogen or hydroxy; R ^ 2 ^ is hydrogen or hydroxy; or R ^ 1 ^ and R ^ 2 ^ together are oxygen; A is a bond, CH ~ 2 ~, CHCH ~ 3 ~, CH ~ 2 ~ CH ~ 2 ~ or C (CH ~ 3 ~) ~ 2 ~; R ^ 3 ^ and R ^ 4 ^ are identical or different and are hydrogen, halo, C ~ 1-6 ~ alkyl, C ~ 1-4 ~ alkoxy, methyl trifluorine, NO ~ 2 ~, COR ^ 6 ^, COOR ^ 6 ^ or NR ^ 6 ^ R ^ 7 ^, where R ^ 6 ^ and R ^ 7 ^ are identical or different and are hydrogen, C ~ 1-6 ~ alkyl or benzyl; R ^ 5 ^ is hydrogen, C ~ 1-6 ~ alkyl, C ~ 2-6 ~ alkenyl, C ~ 3-6 ~ cycloalkyl, (O = C) -C ~ 1-6 ~ alkyl, (O = C) -C ~ 2-6 ~ alkenyl, (O = C) -C ~ 3-6 ~ cycloalkyl, wherein said alkyl, alkenyl and cycloalkyl groups can be replaced with 1, 2 or 3 selected halo groups, C ~ 3 -6 ~ cycloalkyl, phenyl or substituted phenyl, and their salts, are particularly useful for treating, among other indications, neuropathic pain and other CNS disorders.

BR0011427-8A 1999-06-07 2000-06-07 Tricyclic painkillers BR0011427A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13786899P 1999-06-07 1999-06-07
PCT/EP2000/005783 WO2000075116A2 (en) 1999-06-07 2000-06-07 Tricyclic analgesics

Publications (1)

Publication Number Publication Date
BR0011427A true BR0011427A (en) 2002-03-26

Family

ID=22479397

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0011427-8A BR0011427A (en) 1999-06-07 2000-06-07 Tricyclic painkillers

Country Status (21)

Country Link
EP (1) EP1235808A2 (en)
JP (1) JP2003513006A (en)
KR (1) KR20020010923A (en)
CN (1) CN1635998A (en)
AP (1) AP2001002356A0 (en)
AU (1) AU6428400A (en)
BG (1) BG106162A (en)
BR (1) BR0011427A (en)
CA (1) CA2376076A1 (en)
EA (1) EA200101117A1 (en)
HR (1) HRP20010913A2 (en)
HU (1) HUP0203317A2 (en)
IL (1) IL146755A0 (en)
IS (1) IS6175A (en)
MA (1) MA26795A1 (en)
MX (1) MXPA01012694A (en)
NO (1) NO20015966L (en)
PL (1) PL357340A1 (en)
SK (1) SK17512001A3 (en)
TR (1) TR200103531T2 (en)
WO (1) WO2000075116A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
FR2915099B1 (en) * 2007-04-19 2009-06-05 Sanofi Aventis Sa USE OF 4-CYCLOPROPYLMETHOXY-N- (3,5-DICHLORO-1-OXYDO-PYRIDIN-4-YL) -5- (METHOXY) PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF CRANIAL TRAUMATISM
WO2012106499A1 (en) * 2011-02-02 2012-08-09 Vertex Pharmaceuticals Incorporated Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
GB201416346D0 (en) * 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives
CN115872873A (en) * 2022-12-29 2023-03-31 上海泰坦科技股份有限公司 Recrystallization purification method of bis (2-bromoethyl) amine hydrobromide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8917069D0 (en) * 1989-07-26 1989-09-13 Merck Sharp & Dohme Therapeutic agents
IL96507A0 (en) * 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
DK0681571T3 (en) * 1993-01-28 1998-11-23 Merck & Co Inc Spiro-substituted azacyclic compounds as tachykinin receptor antagonists
US5439914A (en) * 1994-02-18 1995-08-08 Merck & Co., Inc. Spirocycles
WO1998025604A1 (en) * 1996-12-13 1998-06-18 Merck & Co., Inc. Spiro-substituted azacycles as modulators of chemokine receptor activity
US6013644A (en) * 1997-12-12 2000-01-11 Merck & Co., Inc. Spiro-substituted azacycles as modulators of chemokine receptor activity

Also Published As

Publication number Publication date
IS6175A (en) 2001-11-23
WO2000075116A2 (en) 2000-12-14
MA26795A1 (en) 2004-12-20
CA2376076A1 (en) 2000-12-14
HRP20010913A2 (en) 2003-04-30
AU6428400A (en) 2000-12-28
AP2001002356A0 (en) 2001-12-31
MXPA01012694A (en) 2003-10-15
CN1635998A (en) 2005-07-06
HUP0203317A2 (en) 2003-02-28
NO20015966D0 (en) 2001-12-06
NO20015966L (en) 2001-12-06
TR200103531T2 (en) 2002-06-21
JP2003513006A (en) 2003-04-08
EA200101117A1 (en) 2002-06-27
KR20020010923A (en) 2002-02-06
BG106162A (en) 2002-05-31
SK17512001A3 (en) 2002-11-06
WO2000075116A3 (en) 2002-07-04
PL357340A1 (en) 2004-07-26
EP1235808A2 (en) 2002-09-04
IL146755A0 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
BR9813360A (en) Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors
BR9812095A (en) Indole compounds as cox-2 inhibitors
BR9913592A (en) Compounds, compound preparation process, and pharmaceutical compositions
BR9811521A (en) Composition to treat or prevent glomerulopathy
BR9907300A (en) Substituted oxoaza-heterocyclyl factor x inhibitors
AU636330B2 (en) N-phenyl-n-(4-piperidinyl)amides useful as analgesics
BR9812699A (en) Benzamidine derivatives
BR0002518A (en) 4-arylpiperidine derivatives for the treatment of pruritus
DE69728544D1 (en) TOTAL SYNTHESIS OF ACYL FULVENES WITH ANTITUARY EFFECT
PE20050012A1 (en) BENZOPYRANE COMPOUNDS AS CYCLOOXYGENASE-2 INHIBITORS
BR0100234A (en) Piperidine-4-sulfonamide compounds, process for their preparation and pharmaceutical compositions containing the same
BRPI0413013A (en) compound, its salts, solvates, and pharmaceutically functional derivatives, pharmaceutical composition, use of a compound, and methods for the treatment or prophylaxis of conditions or disorders, and diseases
EE04496B1 (en) Tetrahydro-gamma-carbolines, their preparation and use as medicaments, and compositions containing them
BR0314844A (en) New compound
BR0011427A (en) Tricyclic painkillers
FI844333A0 (en) 11-SUBSTITUERADE 5H, 11H-PYRROLO / 2,1-C / / 1,4 / BENZOXAZEPINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDEL.
FI895046A0 (en) 4-AMINO-3-ACYLKINOLINDERIVAT SAMT DERAS ANVAENDNING SAOSOM INHIBITORER AV SEKRETION AV MATSMAELTNINGSVAETSKOR.
NO934483L (en) Hydroxyamidine derivatives
DK0952159T3 (en) Use of phenylhydrazone derivatives as anti-inflammatory or analgesic agents
BR0015401A (en) [(indol-3-yl) -cycloalkyl] -3-substituted azetidines for the treatment of central nervous system disorders
AR016594A1 (en) DERIVATIVES OF 3,4,5,7-TETRAHIDRO-PIRROLO [3 ', 4': 4,5] TIENO [2,3-d] PIRIMIDINE 3-SUBSTITUTED AND ITS USE FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS
BR9907497A (en) Imidazoline compounds, a process for their preparation and pharmaceutical compounds containing the same
BR0207966A (en) Pharmaceutical composition containing 1,3-thiazine derivatives
BR0002516A (en) Compounds useful in therapy
PE99399A1 (en) PHARMACEUTICAL COMPOUND DERIVED FROM TIADIAZOLO QUINOLEIN

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7O, 8O E 9O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2008 DE 30/06/2009.